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Abstract
Schistosomiasis caused by Schistosoma mansoni, one of the most neglected human parasitoses in Latin America and Africa,
is routinely confirmed by microscopic visualization of eggs in stool. The main limitation of this diagnostic approach is its lack
of sensitivity in detecting individual low worm burdens and consequently data on infection rates in low transmission
settings are little reliable. According to the scientific literature, PCR assays are characterized by high sensitivity and
specificity in detecting parasite DNA in biological samples. A simple and cost effective extraction method for DNA of
Schistosoma mansoni from urine samples in combination with a conventional PCR assay was developed and applied in an
endemic area. This urine based PCR system was tested for diagnostic accuracy among a population of a small village in an
endemic area, comparing it to a reference test composed of three different parasitological techniques. The diagnostic
parameters revealed a sensitivity of 100%, a specificity of 91.20%, positive and negative predictive values of 86.25% and
100%, respectively, and a test accuracy of 94.33%. Further statistical analysis showed a k index of 0.8806, indicating an
excellent agreement between the reference test and the PCR system. Data obtained from the mouse model indicate the
infection can be detected one week after cercariae penetration, opening a new perspective for early detection and patient
management during this stage of the disease. The data indicate that this innovative PCR system provides a simple to handle
and robust diagnostic tool for the detection of S. mansoni DNA from urine samples and a promising approach to overcome
the diagnostic obstacles in low transmission settings. Furthermore the principals of this molecular technique, based on the
examination of human urine samples may be useful for the diagnosis of other neglected tropical diseases that can be
detected by trans-renal DNA.
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Introduction
Schistosomiasis is from a global public health perspective one
of the most important water-borne parasitosis and a major
neglected tropical disease, with more than 200 million people
infected and close to 800 million at risk [1]. The disease burden
is estimated to exceed 70 million disability-adjusted life-years
[2]. Although in the specific case of Schistosoma mansoni
substantial progress has been made in the control of this
disease in Egypt and Latin America by reducing morbidity and
prevalence, transmission continues, and the disease has spread
to previously non-endemic areas [3–5]. Under these circum-
stances, characterized by low prevalence and infection intensity,
the routinely used diagnostic tool, based on the detection of
parasite eggs in stool, the Kato-Katz technique [6], lacks
sensitivity to identify reliably positive cases [7–9]. Consequently
the prevalence in these settings is significantly underestimated
and undetected carriers maintain and spread the disease,
hampering further progress of the control efforts [10]. In order
to overcome the intrinsic limitation of this technique the
examination of various stool samples is necessary, neutralizing
all operational advantages of this method [11–13]. As alterna-
tive, serological tests can be applied together with or without
coproscopic techniques [14]. Available tests present either low
sensitivity, cross-reactivity with other helminth infections or
cannot distinguish between active and past infections, which is
particularly important for endemic areas [15,16]. New candi-
dates for serological diagnostic of schistosomiasis, partly derived
from proteomic analysis, are still in the experimental phase and
require further improvement and validation [17–20]. Also all
these methods require collection of blood, an inconvenience for
their application at large scale [15].
Considering the above mentioned and the yearly rising numbers
of schistosomiasis infected travelers and migrants, who in general
showing very low infection intensity in its early stage, more
sensitive methods for the diagnosis of this disease, are urgently
needed [16,21,22].
Diagnostic techniques based on the Polymerase Chain Reaction
(PCR) rely on the detection of Schistosoma spp. DNA in feces, serum
[23–27], plasma [28] and urine [29] and have shown high
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based on the use of organic solvents or commercial kits making the
process hazardous and/or expensive to work with a large number
of samples. Recently, a cheap salting out and resin method for
DNA extraction from urine samples was described [30], and in
this study its application in combination with a conventional PCR
technique was evaluated. The diagnostic performance of this test
in comparison to a reference test, obtained through coproscopical
examination of four stool samples, in a Brazilian endemic area for
S. mansoni is presented.
Materials and Methods
Study Population
The study had been conducted in Pedra Preta, a small village
in the north of the state Minas Gerais, Brazil, known as endemic
area for S. mansoni (Figure 1). All 214 villagers were invited to
participate in this study and 194 provided the stool and urine
samples required for this study. The study population of 194
participants was composed of 92 females and 102 males, of
whom 66 were under 18 years of age (32 females and 34 males
between 1 and 17 years old). The 128 adults included 60 females
and 68 males between 18 and 86 years old. More detailed
information about age groups and gender is given in Figure 2.
The study protocol and objectives were explained to the
participants and written informed consent was obtained from
all adults and from a parent or legal guardian of minors, in
compliance with the guidelines of the Helsinki Declaration about
research carried out on humans. The study received approval by
the Ethical Review Board of the Rene ´ Rachou Research Center
/ FIOCRUZ - MINAS (No. 03/2008) as well as by the Brazilian
National Ethical Review Board (CONEP - No 784/2008).
Individuals with positive stool examinations for schistosomiasis
were treated with praziquantel and those positive for other
helminth infections with albendazole as recommended by the
Brazilian Ministry of Health.
Stool Examinations
The participants were asked to provide a total number of four
stool samples collected on consecutive days. Twelve Kato Katz
(KK) smears were prepared from the first sample and two smears
from the second, the third and the forth, respectively, resulting in
18 slides for each participant. The cumulative results of all KK
slides per participant combined with two other parasitological
methods, namely the Saline Gradient technique, using 500 mg
feces from the first sample and the Miracidia Hatch test using 1 g
feces from the first sample, served as combined reference test (gold
standard) for comparisons. Both techniques are described in detail
elsewhere [31,32]. The KK slides as well as the material obtained
from the other techniques were examined by three experienced
laboratory technicians.
Urine Examinations
All participants provided one urine sample of 10 ml of morning
urine collected at the same day as the first stool sample. The
samples were received in the field laboratory and stored in a
common freezer and transported frozen to the Rene Rachou
Research Center for further processing. The PCR assays were
conducted and read without previous knowledge of the results
obtained by microscopic examinations of the stool samples, which
were carried out by another team.
DNA extraction from the urine samples was carried out as
recently described by Enk et al [30]. The urine samples were
defrosted, added EDTA to a final concentration of 40 mM and
homogenized by tube inversion. An amount of five mL of each
sample was transferred to a 15 mL Falcon tube and heated in a
water bath at 100uC for 10 min. Five hundred micro liters of 5 M
NaCl was added to each tube. The tubes were shaken vigorously
for 15 sec and placed on ice for 1 hr.
After centrifugation for 10 min at 1,7006g the supernatant was
transferred to another tube. Absolute ethanol, in a quantity of two
times the sample volume, was added, and samples were kept at
220uC for 2 hours for DNA precipitation. The tubes were shaken
vigorously for 15 sec and centrifuged at 1,7006g for 10 min. The
pellet was resuspended in 200 mL 70% ethanol, transferred to a
0,5 mL microcentrifuge tube and centrifuged at 20,0006g for
20 min. The pellets were dried and resuspended in 100 mLo f
DNAse free water and 100 mL of InstaGene matrixH (BioRad).
The samples were incubated at 56uC for 30 min and 100uC for
8 min, vortexed at high speed for 10 sec and centrifuged at
20,0006g for 3 min, the supernatant transferred to a new tube
and used as template for PCR.
The PCR primers were previously designed by Pontes et al.
[23], to amplify a fragment of 110 bp from a highly repeated 121-
basepair sequence of S. mansoni reported by Hamburger
et al,1991(GenBank accession # M61098) [33] that comprises
about 10% of the parasite genome (600,000 copies per cell). As
urine samples contain alongside with human DNA also bacterial,
yeast and in case of our study expected S. mansoni DNA, all samples
were diluted to a total DNA concentration of 2 ng/mL. For
amplification, 2 mL of the extracted DNA from the urine samples
served as template. PCR was carried out with a final volume of
10 mL using 0,8 U of GoTaq DNA polymerase, 1 mL of STR 106
buffer (Promega), 0.1 mg/mLo f1 6 BSA, 0.5 pmol of each,
forward (59 GATCTGAATCCGACCAACCG 39) and reverse (59
ATATTAACGCCCACGCTCTC 39) primers, and enough water
to complete the final volume. A total of 40 amplification cycles
were conducted, each of them consisting of three steps: 30 sec
denaturation at 95uC, 30 sec annealing at 65uC and 30 sec
extension at 72uC. As PCR positive controls, 1 ng of S. mansoni
adult worm DNA was used as template. PCR negative controls
containing all elements of the reaction mixture and water instead
of DNA were also included in each PCR assay as surveillance for
contamination. PCR assays were conducted 3 times for each
sample.
Electrophoresis of 3 ml of the amplified samples was carried out
in 8% polyacrylamide gel using a Mini-Protean II (Bio-Rad,
Hercules, CA). The gel was then silver stained [34] and the images
were recorded by digital photography (Figure 3).
Statistical Analysis
Only data from participants who provided sufficient biological
material to perform the parasitological examinations for the
combined reference test and the PCR from the urine samples were
used to analyze the agreement between these two diagnostic
methods, and to calculate the sensitivity, specificity, positive
predictive value (PPV) and negative predictive value (NPV) of
PCR in urine samples. The comparative analysis for the
performance of the urine PCR in relation to the combined
reference test, and the calculation of the sensitivity, specificity,
PPV, NPV, and k index were done using the OpenEpi Version 2.3
program [35]. The k index was interpreted according to Landis
and Koch [36] indicating excellent agreement between 1.00 and
0.81, good between 0.80 and 0.61, moderate between 0.60 and
0.41, weak between 0.40 and 0.21 and negligible between 0.20
and 0.00.
Diagnosis of S. mansoni Infection in Urine by PCR
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Stool and Urine Examinations
Stool examinations according to the KK technique revealed 22
(11.34%) schistosomiasis positives for 1 slide, 27 (13.92%) for two
and 38 (19.6%) for 12 of the first stool sample. Including the results
of two slides from the second, third and fourth stool samples, the
number of positives increased from 46 (23.71%) to 58 (29.90%)
and 64 (32.99%), respectively. The Saline Gradient technique and
the Miracidia Hatch test detected one and four additional
positives, which were not identified by the KK method, resulting
in a total of 69 (35.57%) infected. This value was considered as
reference for further comparisons.
The PCR technique applied in the urine samples identified 80
of the 194 participants as positive for schistosomiasis, indicating an
infection rate of 41.24%.
Comparison between the PCR Technique and the
Reference Test
The comparison of the results obtained by the Schistosoma PCR
assay of urine samples and the combined reference test as
described above is shown in Table 1.
Diagnostic parameters were calculated revealing a sensitivity of
100% for the PCR assay in urine samples, as none of the positives
found by the combined reference test remained undetected. The
specificity of the molecular technique was high with a value of
91.20% (CI (95%): 84.93–95.02). Positive and negative predictive
values showed figures of 86.25% (CI (95%): 77.03–92.15) and
100% (CI (95%): 96.74–100), respectively. The test accuracy was
94.33% (CI (95%): 90.13–96.8). Further statistical analysis showed
a k index of 0.8806, indicating an excellent agreement between the
two tests.
Discussion
The results of this study clearly show the significant
underestimated schistosomiasis infection rate in this setting and
confirm data published in another study of our group carried out
under similar conditions [10]. The 3.14 fold underestimation of
the number of positives, based on the parasitological techniques
and 3.64 fold of the molecular method, may explain why control
efforts in areas with prevalence lower than 15% are less
successful. The fact that most of the control strategies are based
on the examination of one or two KK slides of a single stool
sample to identify and treat infected, implicates, according to this
data, that only one out of three schistosomiasis positive
individuals is treated. At least 47 positives or 24.25% of the
total population of the village continue to maintain the disease in
this small area and remain at risk to develop chronic and ectopic
forms, especially schistosomal myeloradiculopathy, as well as
indirect pathology and morbidity of the disease, which may
occur even among patients with low individual worm burden
Figure 1. Geographical illustration of the study area situated in the locality of Pedra Preta, municipality of Montes Claros, state of
Minas Gerais, Brazil.
doi:10.1371/journal.pone.0038947.g001
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of an accurate diagnostic tool for individual patient management
and for possible guidance of community based control efforts in
low transmission areas.
Since the discovery of cell-free nucleic acids circulating in blood
and being partially excreted into urine, this field has advanced and
has produced many exciting new developments [39]. Many
publications demonstrate that these nucleic acids could be used for
development of clinical diagnostic PCR-based assays in the areas
of prenatal genetic testing, oncology, organ transplantation, and,
important in this context, infectious and parasitic diseases [40].
DNA fragments from cells that have died throughout the body
appear in the urine, presenting relatively low molecular size
fragments (100–200 bp) which should be considered when
deciding on methods of DNA extraction and PCR design for
analysis. In particular, if PCR is used for amplification and
detection of DNA sequences, as in our case of S. mansoni, the
application of a small sized amplicon significantly enhances
sensitivity. Therefore a pair of primers targeting a sequence of
121 bp was used for PCR, which has been applied extensively in
S. mansoni diagnostics [23,26,27]. With regards to the extraction of
transrenal schistosomiasis DNA, a technique recently described by
our group, which is based on a salting-out and resin procedure,
was applied for the first time among a significant number of
human samples from an endemic area [30]. It reaches an
analytical sensitivity of 1.28 pg of parasite DNA per mL urine.
Since the genome of S. mansoni contains about 580 fg DNA per
cell, our PCR system can, theoretically, detect DNA correspond-
ing to two cells of the multicellular parasite, per mL urine [41].
This analytical sensitivity proofed to be sufficient for following
molecular analysis of urine samples of individuals from an endemic
area.
As table 1 shows, the urine PCR technique did not miss a single
case of schistosomiasis, detected by the reference test, which
Figure 2. Distribution according to gender and age groups of the study population living in Pedra Preta, Minas Gerais, Brazil.
doi:10.1371/journal.pone.0038947.g002
Figure 3. Visualization of 12 PCR assays with silver stained 8%
polyacrylamide gel, showing the expected S. mansoni 110 bp
DNA fragment in positive urine samples. NC: negative control;
L: 100 bp Ladder; PC: positive control; lines 2, 3, 4, 5, 6, and 7: S.
mansoni positive urine samples; lines 1, 8, 9, and 10: S. mansoni
negative urine samples.
doi:10.1371/journal.pone.0038947.g003
Table 1. Comparison of positive and negative results
obtained by PCR in urine samples and the copro-
parasitological reference test for the detection of S. mansoni
infection.
Reference test
PCR urine positive negative total
positive 69 11 80
negative 0 114 114
total 69 125 194
doi:10.1371/journal.pone.0038947.t001
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positives identified by PCR and missed by the reference test,
explains the high specificity of 91.20% (95%CI: 84.93–95.02). It is
worth to note here, that the reference test is of paramount
importance for the evaluation of a new diagnostic test. There exists
a general consensus that parasitological tests have an assumed
specificity of 100% but cannot ensure the same values for
sensitivity [42,43]. In order to establish a more robust sensitivity
of the reference test, three different methods were chosen in this
study, which allowed an exhaustive analysis of the fecal samples.
Even so it is evident that not all schistosomiasis positives were
detected, due to the well recognized daily variation of individual
parasite egg output and uneven distribution of the eggs in the stool
[44,45]. Considering the well accepted compromise between
accuracy and cost, consisting of three different stool samples, each
examined by two KK slides, 15 positives would have been missed
by this approach, and the number of discordant urine PCR
examinations would have increased from 11 to 26, presenting a
decreased artificial specificity of 81.43% (95%CI: 74.18–87.00),
PPV of 67.50% (95%CI: 56.64–76.76) and diagnostic accuracy of
86.6% (95%CI: 81.09–90.69) [46,47]. This example demonstrates
two important issues. First, the dilemma of establishing a standard
for a reference test which could be applied for the evaluation of
new high specific and sensitive diagnostic techniques for schisto-
somiasis, resulting in uncertainty about the determination of
discordant or so called ‘‘false positive results’’ obtained with the
new technique. Second, it seems to be likely that cell free DNA as
well as trans-renal DNA levels are less subjective to fluctuation and
variation as long as the infection remains. A proof for this
assumption is the fact that the examination of a single urine
sample collected on the same day as the first stool sample detected
all positives identified by the reference test, which is based on three
different techniques and examining stool samples of four
consecutive days.
The lack of sensitivity of the reference test might not be the
only explanation for the discordant results. As published by
Sandoval et al. [48], Schistosoma DNA in the urine of mice had
been detected by PCR only one week after infection with
cercariae. These results were confirmed by data from an
experimental study in 15 Swiss mice using our PCR system,
which showed that all mice proofed positive for infection after
five days [49]. Given these findings, it is probable that the PCR
system detects infection in humans during the larval stage or at
least before parasite eggs can be found in the stool, i.e. 30 to 40
days after infection, which can explain the discordant results.
Another remote but plausible reason for discordant results could
be unisexual infection with male worms, which gains more
significance in low transmission settings [9]. Finally, contami-
nation of the samples during the handling procedures must be
considered. Therefore high standards of quality control, such as
physical barriers (separation of rooms and materials, use of
bleach and laminar flow chamber with UV light) were applied
during the procedure. Furthermore contamination as explana-
tion for the discordant results in this case seems to be very
unlikely, as negative controls showed no positive outcome.
Finally this urine based PCR system is characterized by certain
operational advantages. The collection of urine samples stands out
as the most important aspect. In the study described here, all 194
morning urine samples were collected during the first two
consecutive days in the field. In contrast to that, the collection of
the four stool samples, necessary for the reference test, took 12
days. This difference in time for sample collection reduces costs,
principally in the sector of human resources. Another advantage of
this technique is the high diagnostic throughput. One well-trained
technician is able to process 96 urine samples per day, including
extraction, amplification and visualization, of which extraction is
the most work intensive process. Compared to the KK technique a
number of 60 to 70 slides per day, including preparation and
examination is a reasonable quantity for one well trained
technician, not considering the significant loss of diagnostic
accuracy of a single KK slide per sample, as lined out above.
Focusing on high sensitivity and specificity, particularly important
in areas of low transmission of the disease, the diagnostic through-
put of the urine PCR system, as of other PCR systems as well, also
indicates to decrease indirect costs. Again the reduction affects the
sector of human resources, as clearly less time is necessary to
process the 96 urine samples than the processing of 1728 KK
slides, composed of 18 slides of four different stool samples
collected from each of 96 patients, for accurate schistosomiasis
diagnostic as shown in this study.
Estimates of the direct costs of the described urine PCR system
including reagents and consumables are less than US$4.00 per
examination (extraction – US$0.70, amplification – US$2.70 and
visualization – US$0.20), and there is still room for cost reduction
by optimizing the extraction and amplification procedures of the
system. In this context, it is worthwhile to note that our study,
besides evaluating the technique in comparison to the routinely-
used coproscopic method, also intended to minimize costs. This
intent led to the decision to give preference to conventional PCR
over the qPCR technique. Besides much higher costs for sample
examination, the qPCR technique requires much more sophisti-
cated equipment which is, to our knowledge, not available in mid-
level laboratory facilities of schistosomiasis endemic countries and
is limited to research institutions and high-level tertiary care
centers. One might argue that qPCR, although much more
expensive and less available, provides the advantage of not only
identifying the presence of trans-renal DNA in samples, but also
quantifying it and thereby indirectly estimating parasite burden. In
our view this advantage of qPCR loses importance in relation to
the approach presented in this paper when it is applied in areas of
low transmission with the majority of infected individuals having
low worm burdens (e.g., less the 100 epg), and where the routinely
used Kato-Katz technique lacks sensitivity. Therefore the focus of
our study was on the detection of positives while keeping costs as
low as possible. The same considerations, namely the high costs
and less compelling need for quantification, account for why the
PCR-ELISA system described by Gomes et al was not used in this
study [27].
In conclusion the described PCR system using urine samples for
the detection of S. mansoni provides a promising alternative and
additional powerful technique for the diagnosis of the disease. The
ease of sample collection and the high sensibility and specificity of
this system indicate its usefulness and value for the identification of
schistosomiasis infections in low transmission settings and among
individuals with low worm burden, which is especially important
in the context of transmission control and disease surveillance. Its
potential for the diagnosis of infections in the early stage opens a
new perspective for patient management that requires further
investigation.
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